Host intestinal mucosal carbohydrates and glycoproteins

Host intestinal mucosal carbohydrates and glycoproteins constitute the primary physical and chemical barrier of the gastrointestinal tract, essential for maintaining gut homeostasis (PubMed: 22543464). This complex layer is predominantly composed of large, heavily O-glycosylated proteins known as mucins, with MUC2 being the most abundant in the intestine (UniProt: P17640). These glycoproteins provide a scaffold for the mucus layer, which serves to lubricate the intestinal wall, protect the underlying epithelium from mechanical stress and digestive enzymes, and regulate the interaction between the host and the gut microbiota (PubMed: 21683804). In many infectious diseases, pathogens such as Helicobacter pylori or Vibrio cholerae utilize specialized adhesins to bind specifically to the carbohydrate moieties of these glycoproteins to colonize the gut (PubMed: 24216685). Consequently, this layer is a critical target for mucosal protectants like sucralfate and bismuth subsalicylate, which reinforce the barrier, as well as for mucolytic agents like N-acetylcysteine that modify its rheological properties (StatPearls: NBK551527; PubMed: 24841368). Therapeutic strategies also include the use of carbohydrate mimics to competitively inhibit pathogen binding to these host structures, thereby preventing infection and inflammation (PubMed: 16540768). Furthermore, the glycosylation patterns of these molecules are increasingly recognized as biomarkers for inflammatory bowel disease and colorectal cancer progression (PubMed: 24216685).

Other names

Intestinal mucus layerIntestinal glycocalyxIntestinal mucinsMucosal glycoproteinsGastrointestinal glycansMucosal barrier

Drugs targeting this complex act through several mechanisms: mucosal protection by forming a physical barrier over glycoproteins (e.g., sucralfate, bismuth); stimulation of endogenous mucin secretion (e.g., rebamipide, misoprostol); mucolysis via the reduction of disulfide bonds in glycoprotein polymers (e.g., N-acetylcysteine); and competitive inhibition of pathogen binding to host carbohydrate moieties (e.g., anti-adhesion agents).